<p>New Delhi: Zydus Lifesciences on Wednesday said the US health regulator has issued ten observations after inspecting its injectable manufacturing plant near Vadodara in Gujarat.</p><p>The US Food and Drug Administration (USFDA) inspected the facility at Jarod near Vadodara from April 15 to April 23, the drug maker said in a regulatory filing.</p><p>The inspection closed with ten observations, it added.</p>.Patanjali 'misleading' ads row: Bigger public apology appears in papers with names of Ramdev, Acharya Balkrishna.<p>The company will closely work with the USFDA to address and respond to the observations in an expeditious manner, Zydus Lifesciences said.</p><p>Shares of the company were trading 2.79 per cent down at Rs 932.80 apiece on the BSE.</p>
<p>New Delhi: Zydus Lifesciences on Wednesday said the US health regulator has issued ten observations after inspecting its injectable manufacturing plant near Vadodara in Gujarat.</p><p>The US Food and Drug Administration (USFDA) inspected the facility at Jarod near Vadodara from April 15 to April 23, the drug maker said in a regulatory filing.</p><p>The inspection closed with ten observations, it added.</p>.Patanjali 'misleading' ads row: Bigger public apology appears in papers with names of Ramdev, Acharya Balkrishna.<p>The company will closely work with the USFDA to address and respond to the observations in an expeditious manner, Zydus Lifesciences said.</p><p>Shares of the company were trading 2.79 per cent down at Rs 932.80 apiece on the BSE.</p>